Shanghai Henlius Biotech shares soar in Hong Kong after Fosun’s US$690 million buyout offer

Henlius joins a wave of companies that have left Hong Kong’s stock market this year, either through privatisation or voluntary delisting having found themselves undervalued.

via News - South China Morning Post (author: Jiaxing Li)
 
 
Back to Top